[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Baronas et al., 2018 - Google Patents

Slc7a5 regulates Kv1. 2 channels and modifies functional outcomes of epilepsy-linked channel mutations

Baronas et al., 2018

View HTML @Full View
Document ID
2792759046277119763
Author
Baronas V
Yang R
Morales L
Sipione S
Kurata H
Publication year
Publication venue
Nature Communications

External Links

Snippet

Kv1. 2 is a prominent voltage-gated potassium channel that influences action potential generation and propagation in the central nervous system. We explored multi-protein complexes containing Kv1. 2 using mass spectrometry followed by screening for effects on …
Continue reading at www.nature.com (HTML) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9406—Neurotransmitters
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Similar Documents

Publication Publication Date Title
Baronas et al. Slc7a5 regulates Kv1. 2 channels and modifies functional outcomes of epilepsy-linked channel mutations
Duncker et al. Otoferlin couples to clathrin-mediated endocytosis in mature cochlear inner hair cells
Vafabakhsh et al. Conformational dynamics of a class C G-protein-coupled receptor
Mignen et al. STIM1 regulates Ca2+ entry via arachidonate‐regulated Ca2+‐selective (ARC) channels without store depletion or translocation to the plasma membrane
Altier et al. ORL1 receptor–mediated internalization of N-type calcium channels
Liu et al. CRL4ACRBN E3 ubiquitin ligase restricts BK channel activity and prevents epileptogenesis
Chih et al. A ciliopathy complex at the transition zone protects the cilia as a privileged membrane domain
Heine et al. Activity-independent and subunit-specific recruitment of functional AMPA receptors at neurexin/neuroligin contacts
Peng et al. Phase separation of Nur77 mediates celastrol-induced mitophagy by promoting the liquidity of p62/SQSTM1 condensates
Pacheco et al. A cholesterol-binding domain in STIM1 modulates STIM1-Orai1 physical and functional interactions
Guo et al. The BBSome in POMC and AgRP neurons is necessary for body weight regulation and sorting of metabolic receptors
Dvir et al. Long QT mutations at the interface between KCNQ1 helix C and KCNE1 disrupt I KS regulation by PKA and PIP2
Yamashita et al. Developmental shift to a mechanism of synaptic vesicle endocytosis requiring nanodomain Ca2+
Antonelli et al. Pin1-dependent signalling negatively affects GABAergic transmission by modulating neuroligin2/gephyrin interaction
Yamamoto et al. NEK9 regulates primary cilia formation by acting as a selective autophagy adaptor for MYH9/myosin IIA
Bouzo-Lorenzo et al. Distinct phosphorylation sites on the ghrelin receptor, GHSR1a, establish a code that determines the functions of ss-arrestins
Lana et al. Thrombospondin-4 reduces binding affinity of [3H]-gabapentin to calcium-channel α2δ-1-subunit but does not interact with α2δ-1 on the cell-surface when co-expressed
Kadurin et al. LRP1 influences trafficking of N-type calcium channels via interaction with the auxiliary α2δ-1 subunit
Koshimizu et al. Complex formation between the vasopressin 1b receptor, β-arrestin-2, and the μ-opioid receptor underlies morphine tolerance
Tao et al. Erbin interacts with TARP γ-2 for surface expression of AMPA receptors in cortical interneurons
Lee et al. Premature contractions of the bladder are suppressed by interactions between TRPV4 and SK3 channels in murine detrusor PDGFRα+ cells
Harrington et al. Novel role for P2X receptor activation in endothelium‐dependent vasodilation
Rocchi et al. Autoantibodies to synapsin I sequestrate synapsin I and alter synaptic function
Mankouri et al. Kir6. 2 mutations causing neonatal diabetes prevent endocytosis of ATP‐sensitive potassium channels
Bannister et al. CaV1. 2 channel N-terminal splice variants modulate functional surface expression in resistance size artery smooth muscle cells